Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (1807)	5/9/2004 9:28:58 AM
From: Art Bechhoefer	Respond to of 1870

The insider sales may or may not be significant. Here's why. If he sold shares at a loss, he might be able to deduct that against gains elsewhere. He may also believe that it will be at least 30 days before the stock has any chance of recovery, no matter what else happens in regard to ongoing trials. Thus, he can buy back the shares later on in anticipation of future gains, without creating a "wash sale" by buying before the 30 days are up. On the other hand, the sale may reflect financial difficulties based on reluctance of Aventis to provide additional support needed for more trials. On the positive side, and unlike ImClone, the sales took place AFTER the news was made public. Art